The DeWorm3 Study is a series of community cluster randomized controlled trials that aim to determine the feasibility of interrupting soil-transmitted helminth transmission (STH) in focal geographical areas by expanding the targeted population and the frequency of mass drug administration with albendazole.

These findings will support the development of STH program guidelines and innovative delivery strategies.  The DeWorm3 Study is a series of grants to the Natural History Museum, London (NHM) (2015-2021) and the University of Washington (2019-2023).